Zenas BioPharma (ZBIO) Net Equity Issued and Repurchased (2026)

Zenas BioPharma's (ZBIO) quarterly Net Equity Issued and Repurchased came in at $100.0 million in Q1 2026.

Zenas BioPharma (ZBIO) Net Equity Issued and Repurchased (2026) Analysis & Trends

Zenas BioPharma's Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $100.0 million for Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	163.10 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	141.90 Mn
10	Zenas BioPharma	1.72 Bn	1.72 Bn	-	100.00 Mn

Download Data

Date	Value
Mar 31, 2026	100.00 Mn
Mar 31, 2026	100.00 Mn